Active, not recruitingPhase 1NCT05236036

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Studying Astrocytoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Northwestern University
Principal Investigator
Priya U Kumthekar, MD, MD
Northwestern University
Intervention
Mycophenolate Mofetil(drug)
Enrollment
60 enrolled
Eligibility
18 years · All sexes
Timeline
20222029

Study locations (3)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05236036 on ClinicalTrials.gov

Other trials for Astrocytoma

Additional recruiting or active studies for the same condition.

See all trials for Astrocytoma

← Back to all trials